2017 Q3 Form 10-Q Financial Statement
#000117184317006564 Filed on November 02, 2017
Income Statement
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
Revenue | $18.72M | $25.01M |
YoY Change | -25.15% | -2.81% |
Cost Of Revenue | $9.217M | $13.32M |
YoY Change | -30.79% | -4.91% |
Gross Profit | $9.500M | $11.69M |
YoY Change | -18.73% | -0.31% |
Gross Profit Margin | 50.76% | 46.75% |
Selling, General & Admin | $7.950M | $9.810M |
YoY Change | -18.96% | -2.22% |
% of Gross Profit | 83.68% | 83.92% |
Research & Development | $1.540M | $1.309M |
YoY Change | 17.65% | -8.2% |
% of Gross Profit | 16.21% | 11.2% |
Depreciation & Amortization | $990.0K | $1.090M |
YoY Change | -9.17% | 2.83% |
% of Gross Profit | 10.42% | 9.32% |
Operating Expenses | $9.890M | $12.50M |
YoY Change | -20.9% | 0.02% |
Operating Profit | -$390.0K | -$813.0K |
YoY Change | -52.03% | 4.9% |
Interest Expense | $189.0K | $142.0K |
YoY Change | 33.1% | -30.39% |
% of Operating Profit | ||
Other Income/Expense, Net | -$274.0K | -$67.00K |
YoY Change | 308.96% | -79.13% |
Pretax Income | -$664.0K | -$880.0K |
YoY Change | -24.55% | -19.71% |
Income Tax | -$19.00K | $758.0K |
% Of Pretax Income | ||
Net Earnings | -$417.0K | -$1.638M |
YoY Change | -74.54% | 93.39% |
Net Earnings / Revenue | -2.23% | -6.55% |
Basic Earnings Per Share | -$0.01 | -$0.05 |
Diluted Earnings Per Share | -$0.01 | -$0.05 |
COMMON SHARES | ||
Basic Shares Outstanding | 34.84M shares | 34.33M shares |
Diluted Shares Outstanding | 34.84M shares | 34.33M shares |
Balance Sheet
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $5.800M | $5.300M |
YoY Change | 9.43% | -13.11% |
Cash & Equivalents | $5.836M | $5.345M |
Short-Term Investments | ||
Other Short-Term Assets | $4.463M | |
YoY Change | -11.97% | |
Inventory | $21.40M | $21.20M |
Prepaid Expenses | ||
Receivables | $15.27M | $15.12M |
Other Receivables | $4.900M | $4.500M |
Total Short-Term Assets | $47.40M | $46.15M |
YoY Change | 2.7% | -11.79% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $4.300M | $5.267M |
YoY Change | -18.36% | -11.24% |
Goodwill | $39.84M | $39.62M |
YoY Change | 0.54% | -3.02% |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $1.400M | $112.0K |
YoY Change | 1150.0% | -67.91% |
Total Long-Term Assets | $63.30M | $66.02M |
YoY Change | -4.12% | -18.72% |
TOTAL ASSETS | ||
Total Short-Term Assets | $47.40M | $46.15M |
Total Long-Term Assets | $63.30M | $66.02M |
Total Assets | $110.7M | $112.2M |
YoY Change | -1.32% | -16.01% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $5.607M | $6.142M |
YoY Change | -8.71% | -2.85% |
Accrued Expenses | $4.500M | $4.501M |
YoY Change | -0.02% | 17.21% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $2.800M | $2.400M |
YoY Change | 16.67% | -52.0% |
Total Short-Term Liabilities | $13.90M | $14.44M |
YoY Change | -3.75% | -16.38% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $9.700M | $12.67M |
YoY Change | -23.43% | -16.38% |
Other Long-Term Liabilities | $3.500M | $2.600M |
YoY Change | 34.62% | -43.48% |
Total Long-Term Liabilities | $13.20M | $12.67M |
YoY Change | 4.2% | -16.38% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $13.90M | $14.44M |
Total Long-Term Liabilities | $13.20M | $12.67M |
Total Liabilities | $33.80M | $36.29M |
YoY Change | -6.85% | -7.6% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$114.7M | |
YoY Change | 21.28% | |
Common Stock | $417.0K | |
YoY Change | -99.8% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | 7.746M shares | |
Shareholders Equity | $76.90M | $75.89M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $110.7M | $112.2M |
YoY Change | -1.32% | -16.01% |
Cashflow Statement
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$417.0K | -$1.638M |
YoY Change | -74.54% | 93.39% |
Depreciation, Depletion And Amortization | $990.0K | $1.090M |
YoY Change | -9.17% | 2.83% |
Cash From Operating Activities | $2.140M | $3.440M |
YoY Change | -37.79% | -4400.0% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$240.0K | -$540.0K |
YoY Change | -55.56% | -18.18% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | |
YoY Change | -100.0% | |
Cash From Investing Activities | -$240.0K | -$540.0K |
YoY Change | -55.56% | -19.4% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -720.0K | -1.030M |
YoY Change | -30.1% | 151.22% |
NET CHANGE | ||
Cash From Operating Activities | 2.140M | 3.440M |
Cash From Investing Activities | -240.0K | -540.0K |
Cash From Financing Activities | -720.0K | -1.030M |
Net Change In Cash | 1.180M | 1.870M |
YoY Change | -36.9% | -261.21% |
FREE CASH FLOW | ||
Cash From Operating Activities | $2.140M | $3.440M |
Capital Expenditures | -$240.0K | -$540.0K |
Free Cash Flow | $2.380M | $3.980M |
YoY Change | -40.2% | 586.21% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
36000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD | |
CY2017Q3 | us-gaap |
Interest Expense
InterestExpense
|
189000 | USD |
CY2017Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-12000 | USD |
CY2016Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-64000 | USD |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
2604000 | USD | |
us-gaap |
Depreciation
Depreciation
|
1009000 | USD | |
hbio |
Amortization Of Catalog Costs
AmortizationOfCatalogCosts
|
31000 | USD | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1000000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
608000 | USD | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
563000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-786000 | USD | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
35000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-830000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
99000 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
7000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1996000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-716000 | USD | |
us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
2250000 | USD | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
3502000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
-101000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1353000 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
313000 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
240000 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
503000 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
-96000 | USD | |
CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3625000 | USD |
CY2017Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
9737000 | USD |
CY2017Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
875000 | USD |
CY2017Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
10768000 | USD |
CY2017Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
20656000 | USD |
CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
16391000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1739000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1740000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1537000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
1151000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
1133000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
1879000 | USD |
CY2017Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
9179000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
2500000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
2400000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
2200000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
2200000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
2200000 | USD |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2017Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
1181000 | USD |
CY2016Q3 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-2006000 | USD |
CY2017Q3 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
0 | USD |
CY2016Q3 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
11000 | USD |
CY2017Q3 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
-21000 | USD |
CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
785000 | USD |
CY2017Q3 | hbio |
Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
|
41077000 | USD |
CY2017Q3 | hbio |
Total Intangible Assets
TotalIntangibleAssets
|
88742000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
141000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
179000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-98000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
60000 | USD |
CY2017Q3 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
248000 | USD |
CY2016Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
193000 | USD |
CY2016 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
97000 | USD |
CY2016 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
143000 | USD |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001123494 | ||
us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-43000 | USD | |
CY2017Q3 | us-gaap |
Secured Debt
SecuredDebt
|
12439000 | USD |
CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
18904000 | USD |
CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14608000 | USD |
CY2016Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
9340000 | USD |
CY2016Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
823000 | USD |
CY2016Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
9792000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
47665000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-31122000 | USD |
CY2016Q4 | hbio |
Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
|
39241000 | USD |
CY2016Q4 | hbio |
Total Intangible Assets
TotalIntangibleAssets
|
84882000 | USD |
CY2015Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
147000 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
1293771 | shares | |
CY2015Q2 | hbio |
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan
IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan
|
2500000 | shares |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
45641000 | USD |
CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-67000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-28170000 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4096818 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1072653 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
3.15 | |
CY2016Q3 | us-gaap |
Revenues
Revenues
|
25007000 | USD |
CY2016Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
13317000 | USD |
CY2016Q3 | us-gaap |
Gross Profit
GrossProfit
|
11690000 | USD |
CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
12503000 | USD |
CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-813000 | USD |
CY2016Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y0M30D | |
CY2017Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
933000 | USD |
CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-880000 | USD |
CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
758000 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1638000 | USD |
CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' > Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Revenue</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' > from Contracts with Customers, </font><font style='font-family:Times New Roman;font-size:10pt;' >a</font><font style='font-family:Times New Roman;font-size:10pt;' > new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in the </font><font style='font-family:Times New Roman;font-size:10pt;' >United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or service</font><font style='font-family:Times New Roman;font-size:10pt;' >s. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >is in the process of evaluating the impact of the new standard on </font><font style='font-family:Times New Roman;font-size:10pt;' >its consolidated financial position, results of operations and cash</font><font style='font-family:Times New Roman;font-size:10pt;' > flows</font><font style='font-family:Times New Roman;font-size:10pt;' >. As part of this process, the Company has conducted</font><font style='font-family:Times New Roman;font-size:10pt;' > a comprehensive ass</font><font style='font-family:Times New Roman;font-size:10pt;' >essment of its contracts</font><font style='font-family:Times New Roman;font-size:10pt;' > concerning any unique customer contract terms o</font><font style='font-family:Times New Roman;font-size:10pt;' >r transactions that could have implications </font><font style='font-family:Times New Roman;font-size:10pt;' >under the new guidance.</font><font style='font-family:Times New Roman;font-size:10pt;' > T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company has identified its </font><font style='font-family:Times New Roman;font-size:10pt;' >significant</font><font style='font-family:Times New Roman;font-size:10pt;' > revenue streams, which</font><font style='font-family:Times New Roman;font-size:10pt;' > currently consist primarily</font><font style='font-family:Times New Roman;font-size:10pt;' > of </font><font style='font-family:Times New Roman;font-size:10pt;' >product</font><font style='font-family:Times New Roman;font-size:10pt;' > revenue transactions, </font><font style='font-family:Times New Roman;font-size:10pt;' >and to a lesser extent, </font><font style='font-family:Times New Roman;font-size:10pt;' >extended warranty </font><font style='font-family:Times New Roman;font-size:10pt;' >transactions on certain product </font><font style='font-family:Times New Roman;font-size:10pt;' >sales, and revenues </font><font style='font-family:Times New Roman;font-size:10pt;' >from</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >government contract</font><font style='font-family:Times New Roman;font-size:10pt;' >s. T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company is in the process of updating its revenue </font><font style='font-family:Times New Roman;font-size:10pt;' >recognition</font><font style='font-family:Times New Roman;font-size:10pt;' > policy, systems,</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >internal </font><font style='font-family:Times New Roman;font-size:10pt;' >controls in response to the new update. T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company does not expect material changes to the timing of</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >revenue recognition, nor does it expect significant changes to its</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >systems or internal controls</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Finally, t</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company is evaluating the disclosure requirements under the new standard, which are generally more expansive than current guidance. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects these</font><font style='font-family:Times New Roman;font-size:10pt;' > undertaking</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > will be complete in </font><font style='font-family:Times New Roman;font-size:10pt;' >the fourth quarter</font><font style='font-family:Times New Roman;font-size:10pt;' > of 2017.</font><font style='font-family:Times New Roman;font-size:10pt;' > Based on procedures to date, the C</font><font style='font-family:Times New Roman;font-size:10pt;' >ompany does not anticipate material changes </font><font style='font-family:Times New Roman;font-size:10pt;' >to its consolidated financial s</font><font style='font-family:Times New Roman;font-size:10pt;' >tatements</font><font style='font-family:Times New Roman;font-size:10pt;' >. The Company continues to work through the adoption process and it is possible that these preliminary conclusions could change. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In February 2016, the FASB issued ASU 201</font><font style='font-family:Times New Roman;font-size:10pt;' >6-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. </font><font style='font-family:Times New Roman;font-size:10pt;' >The update is effective for fiscal years beginning after December 15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company has commenced the process of evaluating the requirements of the standard as well as collecting information on all its leases. The Company has not yet concluded on the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company’s future commitments under lease obl</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >igations are summarized in Note 10.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May </font><font style='font-family:Times New Roman;font-size:10pt;' >2017, the FASB issued ASU 2017-09,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Stock compensation (Topic 718): Scope of modification accounting </font><font style='font-family:Times New Roman;font-size:10pt;' >which amends the scope of modification accounting for share-based payment arrangements. The ASU provides </font><font style='font-family:Times New Roman;font-size:10pt;' >guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC 718. Specifically, an entity would not apply modification accounting if the fair value</font><font style='font-family:Times New Roman;font-size:10pt;' >, vesting conditions, and classification of the awards are the same immediately before and after the modification. </font><font style='font-family:Times New Roman;font-size:10pt;' >The</font><font style='font-family:Times New Roman;font-size:10pt;' > ASU is effective for annual reporting periods, including interim periods within those annual reporting periods, beginning after December </font><font style='font-family:Times New Roman;font-size:10pt;' >15, 2017. Early adoption is permitted, including adoption in any interim period.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company has evaluated the requirements of this guidance and does not expect the adoption of the standard to have a material impact on its consolidated financial position, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >results of operations and cash flows.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In August</font><font style='font-family:Times New Roman;font-size:10pt;' > 201</font><font style='font-family:Times New Roman;font-size:10pt;' >7, the FASB issued ASU 2017-12, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Derivatives and Hedging (Topic 815)</font><font style='font-family:Times New Roman;font-size:10pt;' > which amends the hedge accounting recognition and presentation requirements in ASC 815. The Board’s objectives in issuing the ASU are to</font><font style='font-family:Times New Roman;font-size:10pt;' > (1) improve the transparency and understandability of information conveyed to financial statement users about an entity’s risk management activities by better aligning the entity’s financial reporting for hedging relationships with those risk management a</font><font style='font-family:Times New Roman;font-size:10pt;' >ctivities and (2) reduce the complexity of and simplify the application o</font><font style='font-family:Times New Roman;font-size:10pt;' >f hedge accounting by preparers. The</font><font style='font-family:Times New Roman;font-size:10pt;' > ASU is effective for annual reporting periods, including interim periods within those annual reporting periods, beginning after December 15, 201</font><font style='font-family:Times New Roman;font-size:10pt;' >8</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font><font style='font-family:Times New Roman;font-size:10pt;' > Early adoption is permitted, including adoption in any interim period.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determined the impact of the adoption on its consolidated financial position, results of operations and cash</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > flows.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;' >, which simplifies the accounting for share-based payment</font><font style='font-family:Times New Roman;font-size:10pt;' > transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The standard requires an entity to recognize all excess tax benefits and tax deficiencies as</font><font style='font-family:Times New Roman;font-size:10pt;' > income tax benefit or expense in the income statement as discrete items in the reporting period in which they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity’s annual effective tax rate, applied on a prospec</font><font style='font-family:Times New Roman;font-size:10pt;' >tive basis. Further, the standard eliminates the requirement to defer the recognition of excess tax benefits until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with any valuation allow</font><font style='font-family:Times New Roman;font-size:10pt;' >ance, should be recognized on a modified retrospective basis as a cumulative adjustment to retained earnings as of the </font><font style='font-family:Times New Roman;font-size:10pt;' >date of adoption. Under ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09, an entity that applies the treasury stock method in calculating diluted earnings per share is requir</font><font style='font-family:Times New Roman;font-size:10pt;' >ed to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since such amounts are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner as other cash fl</font><font style='font-family:Times New Roman;font-size:10pt;' >ows related to income taxes on the statement of cash flows, as such excess tax benefits no longer represent financing activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods presen</font><font style='font-family:Times New Roman;font-size:10pt;' >ted. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company adopted ASU 2016-09 as of January 1, 2017. The Company recorded a cumulative increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred tax assets related to th</font><font style='font-family:Times New Roman;font-size:10pt;' >e prior years’ unrecognized excess tax benefits. An equal amount of valuation allowance was also recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in no net impact to retained earnings and deferred tax </font><font style='font-family:Times New Roman;font-size:10pt;' >assets. In addition, tax deficiencies related to vested restricted stock units and canceled stock options during the </font><font style='font-family:Times New Roman;font-size:10pt;' >nine months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >September 30,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > have been recognized in the current period’s income statement. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09 also allows an enti</font><font style='font-family:Times New Roman;font-size:10pt;' >ty to elect as an accounting policy either to continue to estimate the total number of awards for which the requisite service period will not be rendered or to account for forfeitures for service based awards as they occur. An entity that elects to account</font><font style='font-family:Times New Roman;font-size:10pt;' > for forfeitures as they occur should apply the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earnings as of the date of adoption. The Company elected as an accounting policy to account for forfeitures fo</font><font style='font-family:Times New Roman;font-size:10pt;' >r service based awards as they occur, and as a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings with a corresponding increase in additional paid in capital related to the prior years</font><font style='font-family:Times New Roman;font-size:10pt;' >’ stock-based compe</font><font style='font-family:Times New Roman;font-size:10pt;' >nsation expense</font><font style='font-family:Times New Roman;font-size:10pt;' > as required under the modified retrospective approach. </font><font style='font-family:Times New Roman;font-size:10pt;' > The tax effect of this adjustment, which included the impact of a valuation allowance was immaterial. </font></p><p style='text-align:left;line-height:12pt;' ></p></div> | ||
us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
21000 | USD | |
us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
76000 | USD | |
CY2016Q3 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
156000 | USD |
CY2016Q3 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
168000 | USD |
CY2016Q3 | us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-74000 | USD |
CY2016Q3 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
62000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plans Estimated Future Employer Contributions In Current Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear
|
100000 | USD |
CY2016Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
200000 | USD |
CY2017Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
200000 | USD |
CY2017Q3 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
3400000 | USD |
CY2016Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
3000000 | USD |
CY2017Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5789838 | shares |
CY2016Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5300945 | shares |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
17508929 | shares |
CY2017Q3 | hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
1.24 | |
CY2016Q3 | hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
1.11 | |
dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-09-30 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
hbio |
Estimated Rental Expenses Current Year
EstimatedRentalExpensesCurrentYear
|
1900000 | USD | |
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1400000 | USD | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.027 | pure | |
CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4305 | pure |
CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0101 | pure |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y1M6D | |
us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
762141 | shares | |
hbio |
Additions To Catalog Costs
AdditionsToCatalogCosts
|
-39000 | USD | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.99 | ||
CY2016Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.94 | |
CY2017Q3 | us-gaap |
Revenues
Revenues
|
25050000 | USD |
CY2017Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
13411000 | USD |
CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
11639000 | USD |
CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
11775000 | USD |
CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-136000 | USD |
CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-274000 | USD |
CY2017Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-410000 | USD |
CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7000 | USD |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-417000 | USD |
CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
2596000 | USD | |
us-gaap |
Depreciation
Depreciation
|
1173000 | USD | |
hbio |
Amortization Of Catalog Costs
AmortizationOfCatalogCosts
|
13000 | USD | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
72000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
455000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2145000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-735000 | USD | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
742000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-2785000 | USD | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-158000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
296000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
29000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-954000 | USD | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
6738000 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
468000 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
725000 | USD | |
CY2016Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
943000 | USD |
CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-16658000 | USD |
CY2017Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-12515000 | USD |
us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
1805000 | USD | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
4143000 | USD | |
us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
4100000 | USD | |
CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
15746000 | USD |
CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
19955000 | USD |
CY2017Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
15266000 | USD |
CY2017Q3 | us-gaap |
Goodwill
Goodwill
|
39837000 | USD |
CY2016Q4 | us-gaap |
Goodwill
Goodwill
|
38032000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
17471000 | USD |
CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
16543000 | USD |
CY2017Q3 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
2765000 | USD |
CY2017Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5607000 | USD |
CY2017Q2 | hbio |
Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
|
6000000 | USD |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
80000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3658000 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-443000 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1399000 | USD | |
hbio |
Additions To Catalog Costs
AdditionsToCatalogCosts
|
-34000 | USD | |
CY2017Q2 | hbio |
Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
|
10000000 | USD |
CY2016Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
5400000 | USD |
CY2016Q4 | hbio |
Delayed Drawdown Term Loan
DelayedDrawdownTermLoan
|
4400000 | USD |
CY2016Q4 | hbio |
Revolving Credit Facility
RevolvingCreditFacility
|
4050000 | USD |
CY2016Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
104000 | USD |
CY2017Q3 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
12598000 | USD |
CY2017Q3 | hbio |
Delayed Drawdown Term Loan
DelayedDrawdownTermLoan
|
0 | USD |
CY2017Q3 | hbio |
Revolving Credit Facility
RevolvingCreditFacility
|
0 | USD |
CY2017Q3 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
159000 | USD |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
3.09 | ||
CY2016Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
729000 | USD |
CY2017Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
622000 | USD |
us-gaap |
Revenues
Revenues
|
78106000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
41796000 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
36310000 | USD | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15194000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15979000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4236000 | USD | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2099000 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
411000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
484000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-143000 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-216000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2090000 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
897000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2987000 | USD | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | ||
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-1390000 | USD | |
us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-37000 | USD | |
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
-31000 | USD | |
us-gaap |
Revenues
Revenues
|
74419000 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
39994000 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
34425000 | USD | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15111000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
14144000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4119000 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
38184000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1874000 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-488000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
531000 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-51000 | USD | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
4189000 | USD | |
us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-89000 | USD | |
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
-43000 | USD | |
us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
399000 | USD | |
us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
505000 | USD | |
us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-276000 | USD | |
us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-233000 | USD | |
us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
170000 | USD | |
us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
195000 | USD | |
us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
600000 | USD | |
us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
500000 | USD | |
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1400000 | USD | |
CY2017Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
500000 | USD |
CY2016Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
500000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2596000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2604000 | USD | |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34156606 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34156606 | shares | |
us-gaap |
Operating Expenses
OperatingExpenses
|
35199000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-774000 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1141000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-122000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1915000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1864000 | USD | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34705947 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34705947 | shares | |
CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5836000 | USD |
hbio |
Libor Fixed Rate
LiborFixedRate
|
0.0186 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y2M15D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y1M29D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.413 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0188 | pure | |
hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
1.17 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
|
0.85 | pure | |
CY2017Q3 | hbio |
Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
|
0.2 | pure |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5789838 | shares | |
CY2016Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
39353 | shares |
CY2017Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
36902 | shares |
us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
762141 | shares | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.429 | pure | |
us-gaap |
Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
|
100000 | USD | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1825000 | USD | |
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD | |
hbio |
Non Cash Restructuring Charge
NonCashRestructuringCharge
|
0 | USD | |
CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5345000 | USD |
CY2017Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
CY2016Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
676000 | USD |
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
676000 | USD | |
hbio |
Non Cash Restructuring Charge
NonCashRestructuringCharge
|
-27000 | USD | |
hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
1.21 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5300945 | shares | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
920000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
677000 | USD |